市場調査レポート

商品コード

1649607

エクソソーム研究用製品の市場規模、シェア、成長分析：製品別、適応症別、用途別、製造サービス別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

Exosome Research Products Market Size, Share, and Growth Analysis, By Product, By Indication, By Application, By Manufacturing Service, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年02月01日
発行: SkyQuest
ページ情報: 英文 221 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

エクソソーム研究用製品の世界市場規模は2023年に1億5,579万米ドルとなり、予測期間（2025-2032年）のCAGRは15.9%で、2024年の1億8,056万米ドルから2032年には5億8,788万米ドルに成長する見通しです。

エクソソーム研究用製品市場は、学術研究機関、製薬・バイオテクノロジー企業、病院、臨床試験からの関心の高まりによって大きな成長を遂げています。エクソソーム研究に対する需要の急増は、その診断の可能性と細胞間コミュニケーターとしての新たな役割に起因しています。臨床試験で世界的に試験された物質は6,000を超え、2022年時点の医薬品研究開発費は68％増という驚異的な伸びを示しており、市場の勢いは強いです。世界保健機関（WHO）は、がん関連死が2020年には1,000万人近くに達するという憂慮すべき増加を強調しており、研究者はがん発見のためのバイオマーカーを特定する必要に迫られています。心血管疾患や関節リウマチを含む慢性疾患の罹患率の上昇と相まって、医薬品需要は今後数年間、エクソソーム研究用製品市場のさらなる成長を促進することになると思われます。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Thermo Fisher Scientific Inc.（United States）
QIAGEN N.V.（Germany）
Lonza Group Ltd.（Switzerland）
Miltenyi Biotec（Germany）
Key Developments
Danaher Corporation（United States）
Hologic Inc.（United States）
Fujifilm Holdings Corporation（Japan）
Hitachi Chemical Diagnostics Inc.（Japan）
MBL International（United States）
Novus Biologicals（United States）
System Biosciences（SBI）（United States）
NanoSomix Inc.（United States）
Norgen Biotek Corp.（Canada）
AMS Biotechnology（Europe）Limited（United Kingdom）
Aethlon Medical Inc.（United States）
Capricor Therapeutics Inc.（United States）
Creative Medical Technology Holdings Inc.（United States）
Evox Therapeutics Ltd.（United Kingdom）

結論と推奨事項

Product Code: SQMIG35A2983

Global Exosome Research Products Market size was valued at USD 155.79 million in 2023 and is poised to grow from USD 180.56 million in 2024 to USD 587.88 million by 2032, growing at a CAGR of 15.9% during the forecast period (2025-2032).

The exosome research products market is witnessing significant growth driven by heightened interest from academic research institutes, pharmaceutical and biotechnology companies, hospitals, and clinical trials. The surge in demand for exosome studies stems from their diagnostic potential and emerging role as intercellular communicators. With over 6,000 substances tested globally in clinical trials-an impressive 68% rise in pharmaceutical R&D spending as of 2022-the market's momentum is strong. The World Health Organization has highlighted the alarming rise in cancer-related deaths, with nearly 10 million in 2020, further pressing researchers to identify biomarkers for cancer detection. Coupled with the rising incidence of chronic diseases, including cardiovascular issues and rheumatoid arthritis, the demand for pharmaceutical drugs is set to propel further growth in the exosome research products market in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Exosome Research Products market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Exosome Research Products Market Segments Analysis

Global Exosome Research Products Market is segmented by Product, Indication, Application, Manufacturing Service, End User and Region. Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Indication, the market is segmented into Cancer Indication, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases and Other Diseases. Based on Application, the market is segmented into Biomarkers, Vaccine Development, Tissue Regeneration and Other applications. Based on Manufacturing Service, the market is segmented into Stem cell-derived exosome manufacturing services, Dendritic cell-derived exosome manufacturing services and Other manufacturing services. Based on End User, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies and Hospitals & Clinical Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Exosome Research Products Market

The growing recognition of exosomes as crucial components in intercellular communication, biomarker identification, and understanding disease mechanisms is significantly boosting interest in exosome-related products. Researchers are delving into the versatile applications of exosomes for diagnostics, therapeutic solutions, and drug delivery systems. This heightened focus on the potential of exosomes as valuable tools in various biomedical fields is driving an increasing demand for research products specifically designed for exosome studies. As the significance of exosomes continues to be acknowledged, the global market for exosome research products is set to expand, reflecting the ongoing advancements in scientific exploration and innovation.

Restraints in the Global Exosome Research Products Market

The Global Exosome Research Products market faces significant challenges due to the substantial heterogeneity of exosomes in terms of their size, composition, and cargo. This variability complicates their isolation, characterization, and functional analysis. Furthermore, the intricate nature of exosome biology, combined with the absence of standardized protocols, can hinder reproducibility and complicate data interpretation in exosome studies. These factors collectively present obstacles for researchers, impacting their ability to draw consistent and reliable conclusions, thus restraining progress in the field and potentially limiting market growth for exosome research products.

Market Trends of the Global Exosome Research Products Market

The global exosome research products market is witnessing a significant trend towards the adoption of advanced isolation and analytical technologies. Researchers are increasingly focused on developing sophisticated methods to isolate exosomes from complex biological samples, such as blood, urine, and tissue fluids, ensuring high purity and yield. This trend is driven by a rising demand for integrated systems that facilitate comprehensive characterization and functional analysis of exosomes, encompassing their delivery molecules, surface markers, and biological activities. As the scientific community strives for more precision in exosome research, the market is expected to expand, fostering innovation and enhancing product offerings.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Exosome Research Products Market Size by Product & Service & CAGR (2025-2032)

Market Overview
Kits & Reagents
- Antibodies
- Isolation, Purification, Quantitation Kits, and reagents
- Other kits & reagents
Instruments
Services

Global Exosome Research Products Market Size by Indication & CAGR (2025-2032)

Market Overview
Cancer Indication
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Other Cancers
Neurodegenerative Diseases
Cardiovascular Diseases
Infectious Diseases
Other Diseases

Global Exosome Research Products Market Size by Application & CAGR (2025-2032)

Market Overview
Biomarkers
Vaccine Development
Tissue Regeneration
Other applications

Global Exosome Research Products Market Size by Manufacturing Service & CAGR (2025-2032)

Market Overview
Stem cell-derived exosome manufacturing services
Dendritic cell-derived exosome manufacturing services
Other manufacturing services

Global Exosome Research Products Market Size by End User & CAGR (2025-2032)

Market Overview
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Clinical Laboratories

Global Exosome Research Products Market Size & CAGR (2025-2032)

North America (Product & Service, Indication, Application, Manufacturing Service, End User)
- US
- Canada
Europe (Product & Service, Indication, Application, Manufacturing Service, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product & Service, Indication, Application, Manufacturing Service, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product & Service, Indication, Application, Manufacturing Service, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product & Service, Indication, Application, Manufacturing Service, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi Chemical Diagnostics Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MBL International (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novus Biologicals (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
System Biosciences (SBI) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoSomix Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norgen Biotek Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AMS Biotechnology (Europe) Limited (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aethlon Medical Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Capricor Therapeutics Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Medical Technology Holdings Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evox Therapeutics Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

エクソソーム研究用製品の市場規模、シェア、成長分析：製品別、適応症別、用途別、製造サービス別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

Exosome Research Products Market Size, Share, and Growth Analysis, By Product, By Indication, By Application, By Manufacturing Service, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

エクソソーム研究用製品市場規模：製品別& CAGR（2025-2032）

エクソソーム研究用製品市場規模：適応症別& CAGR（2025-2032）

エクソソーム研究用製品市場規模：用途別& CAGR（2025-2032）

エクソソーム研究用製品市場規模：製造サービス別 & CAGR（2025-2032）

エクソソーム研究用製品市場規模：エンドユーザー別& CAGR（2025-2032）

エクソソーム研究用製品市場規模：地域別& CAGR（2025-2032）